Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study

NCT02369497 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2015-02-24

No results posted yet for this study

Summary

This is a prospective study on the Ascension HRA device to collect data to assess the safety and effectiveness of the HRA.

Conditions

Interventions

DEVICE

HRA

Humeral head resurfacing with the HRA device

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Candi Langmaid, MPH, CCRP · Integra LifeSciences

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02369497 on ClinicalTrials.gov